What is the most likely diagnosis and appropriate management for a patient 9 hours post‑trauma presenting with ethmoid sinus headache radiating to the glabellar area and temples, watery nasal discharge, dry cough, sensation of phlegm stuck in the throat, no relief from mefenamic acid, a history of allergic rhinitis treated with azelastine hydrochloride and fluticasone propionate nasal sprays, asthma managed with budesonide/formoterol inhaler, and an ibuprofen allergy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Most Likely Diagnosis: Acute Viral Rhinosinusitis with Underlying Allergic Rhinitis

This patient presents with acute viral rhinosinusitis (symptoms < 10 days) superimposed on incompletely controlled allergic rhinitis, not acute bacterial rhinosinusitis, and should be managed with intensified intranasal therapy and supportive care without antibiotics at this time. 1

Clinical Reasoning

Why This Is Viral, Not Bacterial

  • The 9-hour symptom duration falls far short of the ≥10-day threshold required to diagnose acute bacterial rhinosinusitis (ABRS). 1, 2 The American Academy of Otolaryngology–Head and Neck Surgery defines ABRS by symptoms persisting ≥10 days without improvement or by "double worsening" (initial improvement followed by deterioration within 10 days). 3, 1

  • Purulent discharge and sinus headache alone cannot distinguish bacterial from viral infection—98–99.5% of acute rhinosinusitis cases are viral. 1, 2 Green or yellow mucus reflects neutrophil content, not bacterial infection. 1

  • All vital signs are normal and the physical exam is unremarkable, which argues against bacterial superinfection or complications. 4

Underlying Allergic Rhinitis

  • The patient's recent epistaxis, ongoing use of azelastine/fluticasone nasal spray with only "temporary relief," and history of allergic rhinitis indicate inadequate control of the underlying allergic inflammation. 3 This predisposes to viral upper respiratory infections and secondary sinus symptoms. 3

  • Asthma is a chronic condition that modifies rhinosinusitis management and signals more severe airway inflammation. 3


Immediate Management Plan

1. Continue and Optimize Intranasal Therapy

  • Continue azelastine/fluticasone (Dymista) nasal spray 2 sprays per nostril twice daily. The fixed combination of intranasal antihistamine plus corticosteroid is the most effective monotherapy for allergic rhinitis and provides rapid symptom relief (onset 5 minutes). 5, 6, 7, 8 It is superior to either agent alone or to oral antihistamine plus intranasal corticosteroid. 3, 6, 7

  • Add high-volume saline nasal irrigation (e.g., 240 mL per nostril twice daily using a squeeze bottle or neti pot) to enhance mucociliary clearance and reduce viral load. 1, 2 This is strongly recommended as adjunctive therapy for both viral rhinosinusitis and allergic rhinitis. 1

2. Symptomatic Relief

  • Switch from mefenamic acid to acetaminophen 1000 mg every 6 hours or naproxen 500 mg twice daily (the patient is allergic to ibuprofen). 1 Analgesics target headache and facial pain. 3, 1

  • Recommend supportive measures: adequate hydration (≥2 L/day), rest, warm facial compresses over the ethmoid/frontal sinuses for 10–15 minutes three times daily, steamy showers, and sleeping with the head of the bed elevated 30–45°. 3, 1 These measures improve sinus drainage and patient comfort. 1

  • Short-term oral decongestant (pseudoephedrine 60 mg every 6 hours, maximum 3–5 days) may be used for severe nasal congestion, but avoid topical decongestant sprays to prevent rhinitis medicamentosa. 3, 1

3. Asthma Monitoring

  • Ensure the patient continues budesonide/formoterol (Symbicort) 160/4.5 mcg two inhalations twice daily as prescribed. 9 Viral upper respiratory infections can trigger asthma exacerbations. 3

  • Instruct the patient to monitor for increased cough, wheezing, chest tightness, or shortness of breath and to use a rescue inhaler (short-acting β₂-agonist) as needed. 9


When to Reassess and Consider Antibiotics

Criteria for Acute Bacterial Rhinosinusitis

Reassess at day 10–14 if symptoms have not improved, or immediately if symptoms worsen at any time. 1, 2 Diagnose ABRS and initiate antibiotics if:

  1. Symptoms persist ≥10 days without improvement, or
  2. "Double worsening": initial improvement followed by worsening within 10 days (increased purulent discharge, facial pain, or fever). 3, 1, 2

First-Line Antibiotic

  • Amoxicillin 500 mg three times daily for 10–14 days is the preferred agent, covering Streptococcus pneumoniae and Haemophilus influenzae. 3, 1, 2

Alternatives (Penicillin Allergy)

  • Doxycycline 100 mg twice daily, trimethoprim-sulfamethoxazole DS twice daily (adults only), or a macrolide (azithromycin 500 mg day 1, then 250 mg daily × 4 days). 3, 1, 2

Escalation for Treatment Failure

  • If no improvement after 3–5 days of amoxicillin, switch to high-dose amoxicillin-clavulanate (2000 mg/125 mg twice daily) to cover β-lactamase–producing organisms. 3, 1, 2

Red-Flag Symptoms Requiring Urgent Evaluation

Instruct the patient to seek immediate care if any of the following develop:

  • Orbital signs: periorbital edema, erythema, proptosis, abnormal eye movements, vision changes, or ocular pain. 1, 2
  • Intracranial signs: severe headache with altered mental status, neck stiffness, cranial nerve deficits, or seizures. 1, 2
  • Facial swelling or erythema over the involved sinus, suggesting cellulitis. 1, 2
  • High fever >39°C with severe unilateral facial pain or signs of sepsis. 1, 2

These findings indicate possible orbital or intracranial complications and require urgent CT imaging, intravenous antibiotics, and specialist consultation (ENT, ophthalmology, neurosurgery). 1, 2


Imaging: Not Indicated

  • Do not order sinus CT, MRI, or plain radiographs for uncomplicated acute rhinosinusitis. 3, 1, 2 Imaging cannot distinguish viral from bacterial infection, and up to 40% of asymptomatic adults have abnormal sinus CT findings. 1, 2

  • Reserve CT for suspected complications (red-flag signs above) or treatment failure after 21–28 days of appropriate antibiotics. 3, 1, 2


Follow-Up and Patient Education

Scheduled Reassessment

  • Telephone or in-person follow-up at day 10–14 if symptoms have not resolved. 1, 2 At that visit, reassess for ABRS criteria and initiate antibiotics if indicated. 1, 2

  • If symptoms improve but are not fully resolved by day 10–14, continue intranasal corticosteroid and saline irrigation for an additional week. 1

Patient Instructions

  • Viral rhinosinusitis typically resolves within 7–10 days with symptomatic care; complete resolution may take up to 2 weeks. 1

  • Return immediately if symptoms worsen at any time (increased pain, fever, purulent discharge) or if red-flag signs develop. 1, 2

  • Antibiotics are ineffective for viral illness and contribute to antimicrobial resistance. 3, 1

Addressing Recurrent Episodes

  • If the patient experiences ≥3 sinusitis episodes per year, evaluate for underlying allergic rhinitis (already diagnosed), anatomic abnormalities (deviated septum, polyps), or immunodeficiency. 3, 1 Consider referral to ENT or allergy/immunology. 3, 1

  • Optimize long-term allergic rhinitis control with continuous intranasal corticosteroid therapy (not just as-needed use) to reduce the frequency of viral upper respiratory infections and secondary sinusitis. 3, 7


Common Pitfalls to Avoid

  1. Do not prescribe antibiotics based solely on purulent discharge, headache, or symptom duration <10 days. 3, 1, 2 This leads to unnecessary antibiotic exposure, resistance, and adverse effects (the number needed to harm with antibiotics in acute rhinosinusitis is 8). 4

  2. Do not order sinus imaging in uncomplicated cases. 3, 1, 2 It adds cost, radiation exposure, and does not change management.

  3. Do not use topical decongestant sprays (oxymetazoline, phenylephrine) for >3–5 days—they cause rebound congestion (rhinitis medicamentosa). 3

  4. Do not assume the patient's allergic rhinitis is well controlled simply because they are using azelastine/fluticasone. The report of "temporary relief" suggests inadequate dosing, poor technique, or need for adjunctive therapy (saline irrigation, oral antihistamine). 3, 7

  5. Do not overlook asthma monitoring. Viral infections are a common asthma trigger; ensure the patient has a rescue inhaler and knows when to escalate therapy. 3, 9


Summary of Next Steps

  1. Continue azelastine/fluticasone nasal spray 2 sprays per nostril twice daily. 5, 6, 7
  2. Add high-volume saline nasal irrigation twice daily. 1, 2
  3. Switch to acetaminophen or naproxen for headache (avoid ibuprofen). 1
  4. Recommend supportive measures (hydration, rest, warm compresses, steam, head elevation). 3, 1
  5. Short-term oral pseudoephedrine (≤5 days) if severe congestion. 3, 1
  6. Continue Symbicort for asthma; monitor for exacerbation. 9
  7. Reassess at day 10–14 or immediately if symptoms worsen. 1, 2
  8. Initiate amoxicillin 500 mg TID × 10–14 days only if ABRS criteria are met at reassessment. 3, 1, 2
  9. Educate on red-flag symptoms requiring urgent evaluation. 1, 2
  10. No imaging unless complications are suspected. 3, 1, 2

References

Guideline

Management of Acute Viral Rhinosinusitis (≤ 7 Days)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Acute Bacterial Rhinosinusitis Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Viral Upper Respiratory Infection Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Intranasal Azelastine and Fluticasone as Combination Therapy for Allergic Rhinitis: Systematic Review and Meta-analysis.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.